BPMC

Blueprint Medicines

Delisted

BPMC was delisted on the 17th of July, 2025.

234 hedge funds and large institutions have $4.39B invested in Blueprint Medicines in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 88 increasing their positions, 67 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

10% more funds holding

Funds holding: 213234 (+21)

1.46% more ownership

Funds ownership: 102.35%103.81% (+1.5%)

21% less call options, than puts

Call options by funds: $43.6M | Put options by funds: $55.5M

Holders
234
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$43.6M
Puts
$55.5M
Net Calls
Net Calls Change

Top Buyers

1 +$59.9M
2 +$41.1M
3 +$24.6M
4
First Manhattan
First Manhattan
New York
+$24.2M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$24.1M

Top Sellers

1 -$105M
2 -$59.6M
3 -$41.9M
4
Norges Bank
Norges Bank
Norway
-$32.2M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$31.2M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$385M
2
$384M
3
$293M
4
$280M
5
$147M
6
$127M
7
$121M
8
$106M
9
$105M
10
$97.8M
11
$93.4M
12
$91.3M
13
$90.2M
14
$87M
15
$82.1M
16
$74.9M
17
$68.5M
18
$64.2M
19
$60M
20
$58M
21
$57.6M
22
$55.6M
23
$55.5M
24
$54.8M
25
$53.7M